Northwestern Mutual Wealth Management CO Sorrento Therapeutics, Inc. Transaction History

Northwestern Mutual Wealth Management CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$1.51 - $2.88 $247 - $472	164 Added 16400.0%	165 $0
Q1 2022 May 09, 2022	BUY	$2.0 - $4.9 $2 - $4	1 New	1 $0
Q1 2021 May 14, 2021	SELL	$7.03 - $16.51 $10,545 - $24,765	-1,500 Closed	0 $0
Q4 2020 Feb 12, 2021	SELL	$5.76 - $11.95 $2,016 - $4,182	-350 Reduced 18.92%	1,500 $10,000
Q3 2020 Nov 13, 2020	BUY	$6.17 - $18.82 $2,159 - $6,587	350 Added 23.33%	1,850 $21,000
Q2 2020 Aug 14, 2020	SELL	$1.73 - $6.76 $865 - $3,380	-500 Reduced 25.0%	1,500 $9,000
Q4 2019 Feb 13, 2020	BUY	$1.45 - $4.17 $2,900 - $8,340	2,000 New	2,000 $7,000

5.47M

Ticker SRNE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 449,952,000
Market Cap $148M
Description
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...

Get notified when there are updates to the investment portfolio of Northwestern Mutual Wealth Management CO, based on Form 13F filings with the SEC.

Stay updated on Northwestern Mutual Wealth Management CO with notifications on news.